In This Section
Advertisement
Issues & Advocacy
SNMMI's mission with regard to health policy and regulatory affairs is to enhance its credibility, advance its issues, and through leadership become a valued partner among public policy stakeholders.
LATEST NEWS
- August 16, 2018 —
Aetna Expands Coverage for Gallium-68 DOTATATE
Aetna has changed its policy to expand coverage for Gallium-68 DOTATATE. - August 15, 2018 —
SNMMI Seeks Comments on BlueCross BlueShield of Tennessee's Proposed Changes to PET Coverage
A new BlueCross Blueshield draft coverage policy was released that includes changes to PET oncologic applications. - August 13, 2018 —
SNMMI Encourages FDA to Alleviate Shortage of Gallium-68
SNMMI outlines the shortage of Gallium-68, its causes and suggests ways the FDA could help. - August 6, 2018 —
USP Opens Call for Volunteers to Serve on Expert Committees
The United States Pharmacopeia is in need of qualified volunteers in the areas of chemical medicines, compounding, and other radiopharmaceutical-related fields. - July 27, 2018 —
USP Releases Chapter 825 on Radiopharmaceuticals
A summary of this new chapter on radiopharmaceuticals is provided here. SNMMI had recommended that a new chapter be established and now looks forward to reviewing it and providing comments. Members are also encouraged to submit comments. - July 26, 2018 —
CMS Proposes 2019 Outpatient Payment Rules
CMS's Proposed Hospital Outpatient Rule has been released. Fees are up slightly. - July 25, 2018 —
The NRC Adopts Many of SNMMI's Recommendations in Final Rule on Medical Use of Byproduct Material
NRC releases amendments related to medical event reporting, training and experience, and measuring molybdenum concentration, among other provisions. - July 19, 2018 —
SNMMI Supports Bill Funding Mo-99 Domestic Production
In a letter to the Senate and House subcommittees on Energy and Water Development, SNMMI President Satoshi Minoshima, MD, PhD, joined with leaders of other medical societies, patient groups, radiopharmaceutical manufacturers and distributors, and medical imaging companies to urge support of a provision in both the Senate and House bills that would provide $20 million in additional funding to continue establishing domestic production of Mo-99.
Click For More Government Relations News
Quicklinks
-
Member Categories & Dues
-
Councils
Learn more about Councils here. -
SNMMI Committees